Lineage Cell Therapeutics, Inc. (LCTX)
AMEX·Healthcare·Biotechnology
$1.57
+0.97%
Mkt Cap $386.09M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $1.96M | $6.60M | +236.81% | -$0.04 | $0.00 | +109.23% | — | — |
| Q4 2025 Nov 6, 2025 | $1.96M | $3.68M | +87.85% | -$0.02 | -$0.13 | -550.00% | — | — |
| Q3 2025 Aug 12, 2025 | $1.89M | $2.77M | +46.38% | -$0.02 | -$0.01 | +50.00% | — | — |
| Q2 2025 May 13, 2025 | $1.72M | $1.50M | -12.89% | -$0.02 | -$0.02 | +0.00% | — | — |
| Q1 2025 Mar 10, 2025 | $1.36M | $2.87M | +110.73% | -$0.04 | -$0.01 | +75.00% | — | — |
| Q4 2024 Nov 14, 2024 | $1.62M | $3.78M | +133.10% | -$0.01 | -$0.02 | -53.49% | — | — |
| Q3 2024 Aug 8, 2024 | $970.00K | $1.41M | +45.15% | -$0.05 | -$0.03 | +40.00% | — | — |
| Q2 2024 May 9, 2024 | $1.36M | $1.44M | +6.18% | -$0.04 | -$0.04 | -4.36% | — | — |
| Q1 2024 Mar 7, 2024 | $1.31M | $2.09M | +59.39% | -$0.02 | -$0.03 | -29.98% | — | — |
| Q4 2023 Nov 9, 2023 | $1.13M | $1.25M | +10.27% | -$0.04 | -$0.04 | -6.67% | — | — |
| Q3 2023 Aug 10, 2023 | $2.20M | $3.23M | +46.59% | -$0.02 | -$0.03 | -32.28% | — | — |
| Q2 2023 May 11, 2023 | $2.01M | $2.39M | +18.71% | -$0.02 | -$0.03 | -21.75% | — | — |
| Q1 2023 Mar 9, 2023 | $2.57M | $1.92M | -25.49% | -$0.03 | -$0.03 | -19.24% | — | — |
| Q4 2022 Nov 10, 2022 | $3.90M | $3.00M | -23.07% | -$0.04 | -$0.04 | -14.29% | — | — |
| Q3 2022 Aug 11, 2022 | $3.68M | $4.55M | +23.59% | -$0.04 | -$0.04 | -6.67% | — | — |
| Q2 2022 May 12, 2022 | $7.32M | $5.24M | -28.49% | -$0.03 | -$0.04 | -17.65% | — | — |
| Q1 2022 Mar 10, 2022 | $840.00K | $960.00K | +14.29% | -$0.01 | -$0.05 | -264.17% | — | — |
| Q4 2021 Nov 10, 2021 | $2.20M | $2.20M | +0.00% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q3 2021 Aug 12, 2021 | $410.00K | $441.00K | +7.56% | -$0.03 | -$0.03 | -18.20% | — | — |
| Q2 2021 May 13, 2021 | $461.48K | $293.00K | -36.51% | -$0.04 | -$0.06 | -71.43% | — | — |